Web Analytics

3 Latest Announced Rounds

  • $3,200,000
    Seed

    2 Investors

    Hospital & Health Care
    Apr 1st, 2025
  • $35,000,000
    Series A

    3 Investors

    Hospital & Health Care
    Apr 1st, 2025
  • $15,000,000
    Unknown

    2 Investors

    Software Development
    Apr 1st, 2025
$1,996.03M Raised in 59 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Exeliom Biosciences

start up
France - Dijon, Bourgogne-Franche-Comté
  • 21/07/2023
  • Series A
  • $8,898,320

At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication


Related People

Benjamin HadidaFounder

Benjamin Hadida France - Paris, Île-de-France

Biotech company builder and new therapeutic class explorer